CSF and serum biomarkers focusing on cerebral vasospasm and ischemia after subarachnoid hemorrhage

Stroke Research and Treatment

Volumn , Issue , 2013, Pages

  Jung, Carla S ^a,b   Lange, Bettina ^a   Zimmermann, Michael ^a   Seifert, Volker ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BIOLOGICAL MARKER; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HISTIDINE; NEURON SPECIFIC ENOLASE; PROTEIN S100B;

ARTERIOGRAPHY; ARTICLE; BRAIN ISCHEMIA; BRAIN VASOSPASM; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBARACHNOID HEMORRHAGE;

EID: 84874871514     PISSN: None     EISSN: 20420056     Source Type: Journal    
DOI: 10.1155/2013/560305     Document Type: Article

References (45)

1. Sehba F. A., Bederson J. B., Mechanisms of acute brain injury after subarachnoid hemorrhage. Neurological Research 2006 28 4 381 398 2-s2.0-33745643550 10.1179/016164106X114991 (Pubitemid 43967786)
2. Roger V. L., Go A. S., Lloyd-Jones D. M., Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011 123 4 e18 e209
3. Kassell N. F., Sasaki T., Colohan A. R. T., Nazar G., Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985 16 4 562 572 2-s2.0-0021873601 (Pubitemid 15007226)
4. Sehba F. A., Pluta R. M., Zhang J. H., Metamorphosis of subarachnoid hemorrhage research: From delayed vasospasm to early brain injury. Molecular Neurobiology 2011 43 1 27 40 2-s2.0-79951557739 10.1007/s12035-010-8155-z
5. Fergusen S., Macdonald R. L., Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 2007 60 4 658 667 2-s2.0-34147193048 10.1227/01.NEU.0000255396.23280.31
6. Fisher C. M., Roberson G. H., Ojemann R. G., Cerebral vasospasm with ruptured saccular aneurysm-the clinical manifestations. Neurosurgery 1977 1 3 245 248 2-s2.0-0017549862
7. Rabinstein A. A., Friedman J. A., Weigand S. D., McClelland R. L., Fulgham J. R., Manno E. M., Atkinson J. L. D., Wijdicks E. F. M., Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2004 35 8 1862 1866 2-s2.0-3242781840 10.1161/01.STR.0000133132.76983.8e (Pubitemid 38971866)
8. Weir B., Grace M., Hansen J., Rothberg C., Time course of vasospasm in man. Journal of Neurosurgery 1978 48 2 173 178 2-s2.0-0017836563 (Pubitemid 8269962)
9. Kramer A., Fletcher J., Do endothelin-receptor antagonists prevent delayed neurological deficits and poor outcomes after aneurysmal subarachnoid hemorrhage?: a meta-analysis. Stroke 2009 40 10 3403 3406 2-s2.0-70349686725 10.1161/STROKEAHA.109.560243
10. Lad S. P., Hegen H., Gupta G., Deisenhammer F., Steinberg G. K., Proteomic biomarker discovery in cerebrospinal fluid for cerebral vasospasm following subarachnoid hemorrhage. Journal of Stroke and Cerebrovascular Diseases 2012 21 1 30 41
11. Tisdall M. M., Smith M., Cerebral microdialysis: Research technique or clinical tool. British Journal of Anaesthesia 2006 97 1 18 25 2-s2.0-33745684731 10.1093/bja/ael109
12. Sarrafzadeh A., Huax D., Sakowtz O., Benndorf G., Herzog H., Kuechler I., Unterberg A., Acute focal neurological deficits in aneurysmal subarachnoid hemorrhage: Relation of clinical course, CT findings, and metabolite abnormalities monitored with bedside microdialysis. Stroke 2003 34 6 1382 1388 2-s2.0-0037975772 10.1161/01.STR.0000074036.97859.02 (Pubitemid 36693502)
13. Fisher C. M., Kistler J. P., Davis J. M., Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980 6 1 1 9 2-s2.0-0018904811 (Pubitemid 10159923)
14. Jung C. S., Iuliano B. A., Harvey-White J., Espey M. G., Oldfield E. H., Pluta R. M., Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage. Journal of Neurosurgery 2004 101 5 836 842 2-s2.0-7244261765 (Pubitemid 39430979)
15. Hunt W. E., Hess R. M., Surgical risk as related to time of intervention in the repair of intracranial aneurysms. Journal of Neurosurgery 1968 28 1 14 20 2-s2.0-0014236544
16. Teasdale G. M., Drake C. G., Hunt W., Kassell N., Sano K., Pertuiset B., De Villiers J. C., A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. Journal of Neurology Neurosurgery and Psychiatry 1988 51 11 1457 2-s2.0-0024118959
17. Jennett B., Bond M., Assessment of outcome after severe brain damage. A practical scale. Lancet 1975 1 7905 480 484 2-s2.0-0016475167
18. Jung C. S., Oldfield E. H., Harvey-White J., Espey M. G., Zimmermann M., Seifert V., Pluta R. M., Association of an endogenous inhibitor of nitric oxide synthase with cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 2007 107 5 945 950 2-s2.0-37149039563 10.3171/JNS-07/11/0945 (Pubitemid 350255207)
19. Crisi G., Colombo A., De Santis M., CT and cerebral ischemic infarcts. Correlations between morphological and clinical-prognostic findings. Neuroradiology 1984 26 2 101 105 2-s2.0-0021326077 (Pubitemid 14152647)
20. Herrmann M., Vos P., Wunderlich M. T., De Bruijn C. H. M. M., Lamers K. J. B., Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke 2000 31 11 2670 2677 2-s2.0-0033766279
21. Oertel M., Schumacher U., McArthur D. L., Kästner S., Böker D. K., S-100B and NSE: markers of initial impact of subarachnoid haemorrhage and their relation to vasospasm and outcome. Journal of Clinical Neuroscience 2006 13 8 834 840 2-s2.0-33748778267 10.1016/j.jocn.2005.11.030 (Pubitemid 44415475)
22. Weiss N., Sanchez-Peña P., Roche S., Beaudeux J. L., Colonne C., Coriat P., Puybasset L., Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage. Anesthesiology 2006 104 4 658 666 2-s2.0-33645652110 10.1097/00000542-200604000-00008
23. Sanchez-Peña P., Pereira A. R., Sourour N. A., Biondi A., Lejean L., Colonne C., Boch A. L., Al Hawari M., Abdennour L., Puybasset L., S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage. Critical Care Medicine 2008 36 8 2267 2273 2-s2.0-49949117644 10.1097/CCM. 0b013e3181809750
24. Moritz S., Warnat J., Bele S., Graf B. M., Woertgen C., The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage. Journal of Neurosurgical Anesthesiology 2010 22 1 21 31 2-s2.0-75149112301 10.1097/ANA.0b013e3181bdf50d
25. Macdonald R. L., Higashida R. T., Keller E., Mayer S. A., Molyneux A., Raabe A., Vajkoczy P., Wanke I., Bach D., Frey A., Marr A., Roux S., Kassell N., Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). The Lancet Neurology 2011 10 7 618 625 2-s2.0-79958803259 10.1016/S1474-4422(11)70108-9
26. MacDonald R. L., Kassell N. F., Mayer S., Ruefenacht D., Schmiedek P., Weidauer S., Frey A., Roux S., Pasqualin A., Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008 39 11 3015 3021 2-s2.0-55749089548 10.1161/STROKEAHA.108. 519942
27. Vergouwen M. D. I., Ilodigwe D., MacDonald R. L., Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke 2011 42 4 924 929 2-s2.0-79954911257 10.1161/STROKEAHA.110.597914
28. Dreier J. P., Kleeberg J., Alam M., Major S., Kohl-Bareis M., Petzold G. C., Victorov I., Dirnagl U., Obrenovitch T. P., Priller J., Endothelin-1-induced spreading depression in rats is associated with a microarea of selective neuronal necrosis. Experimental Biology and Medicine 2007 232 2 204 213 2-s2.0-33846829562 (Pubitemid 46203288)
29. Dreier J. P., Körner K., Ebert N., Görner A., Rubin I., Back T., Lindauer U., Wolf T., Villringer A., Einhäupl K. M., Lauritzen M., Dirnagl U., Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space. Journal of Cerebral Blood Flow and Metabolism 1998 18 9 978 990 2-s2.0-0031723199 (Pubitemid 28427865)
30. Kleeberg J., Petzold G. C., Major S., Dirnagl U., Dreier J. P., ET-1 induces cortical spreading depression via activation of the ET A receptor/phospholipase C pathway in vivo. American Journal of Physiology 2004 286 4 H1339 H1346 2-s2.0-1642370468 10.1152/ajpheart.00227.2003 (Pubitemid 38381141)
31. Jordan J. D., Nyquist P., Biomarkers and Vasospasm After Aneurysmal Subarachnoid Hemorrhage. Neurosurgery Clinics of North America 2010 21 2 381 391 2-s2.0-77951088540 10.1016/j.nec.2009.10.009
32. Bullock R., Zauner A., Woodward J. J., Myseros J., Choi S. C., Ward J. D., Marmarou A., Young H. F., Factors affecting excitatory amino acid release following severe human head injury. Journal of Neurosurgery 1998 89 4 507 518 2-s2.0-0031706636 (Pubitemid 28440917)
33. Shimada N., Graf R., Rosner G., Heiss W. D., Ischemia-induced accumulation of extracellular amino acids in cerebral cortex, white matter, and cerebrospinal fluid. Journal of Neurochemistry 1993 60 1 66 71 2-s2.0-0027523886 10.1111/j.1471-4159.1993.tb05823.x (Pubitemid 23006703)
34. Hong Z., Xinding Z., Tianlin Z., Liren C., Excitatory amino acids in cerebrospinal fluid of patients with acute head injuries. Clinical Chemistry 2001 47 8 1458 1462 2-s2.0-0034923108 (Pubitemid 32678826)
35. Alessandri B., Doppenberg E., Bullock R., Woodward J., Choi S., Koura S., Young H. F., Glucose and lactate metabolism after severe human head injury: Influence of excitatory neurotransmitters and injury type. Acta Neurochirurgica, Supplement 1999 1999 75 21 24 2-s2.0-0033254491
36. Hashimoto K., Engberg G., Shimizu E., Nordin C., Lindström L. H., Iyo M., Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients. BMC Psychiatry 2005 5, article 6 2-s2.0-26844558198 10.1186/1471-244X-5-6 (Pubitemid 41460720)
37. Hutchinson P. J., O'Connell M. T., Al-Rawi P. G., Kett-White C. R., Gupta A. K., Maskell L. B., Pickard J. D., Kirkpatrick P. J., Increases in GABA concentrations during cerebral ischaemia: a microdialysis study of extracellular amino acids. Journal of Neurology Neurosurgery and Psychiatry 2002 72 1 99 105 2-s2.0-0036145205 10.1136/jnnp.72.1.99 (Pubitemid 34073104)
38. Campbell K., Kalen P., Lundberg C., Wictorin K., Rosengren E., Bjorklund A., Extracellular γ -aminobutyric acid levels in the rat caudate-putamen: monitoring the neuronal and glial contribution by intracerebral microdialysis. Brain Research 1993 614 1-2 241 250 2-s2.0-0027289417 (Pubitemid 23181175)
39. Drew K. L., Pehek E. A., Rasley B. T., Ma Y. L., Green T. K., Sampling glutamate and GABA with microdialysis: Suggestions on how to get the dialysis membrane closer to the synapse. Journal of Neuroscience Methods 2004 140 1-2 127 131 2-s2.0-10344220543 10.1016/j.jneumeth.2004.04.039 (Pubitemid 39625860)
40. Hardy P. M., Barrett G. C., The protein amino acids. Chemistry and Biochemistry of the Amino Acids 1985 Chapman and Hall
41. Fadel M. M., Foley P. L., Kassell N. F., Lee K. S., Histidine attenuates cerebral vasospasm in a rabbit model of subarachnoid hemorrhage. Surgical Neurology 1995 43 1 52 58 2-s2.0-0028952317 10.1016/0090-3019(95)80038-I
42. Butcher S. P., Bullock R., Graham D. I., McCulloch J., Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke 1990 21 12 1727 1733 2-s2.0-0025603178
43. Naritomi H., Sasaki M., Kanashiro M., Kitani M., Sawada T., Flow thresholds for cerebral energy disturbance and Na+ pump failure as studied by in vivo 31P and 32Na nuclear magnetic resonance spectroscopy. Journal of Cerebral Blood Flow and Metabolism 1988 8 1 16 23 2-s2.0-0023857982 (Pubitemid 18045939)
44. Drejer J., Benveniste H., Diemer N. H., Schousboe A., Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro. Journal of Neurochemistry 1985 45 1 145 151 2-s2.0-0021829328 (Pubitemid 15046087)
45. 2+-independent release of glutamate during anoxia in isolated nerve terminals (synaptosomes). Journal of Neurochemistry 1988 50 4 1322 1324 2-s2.0-0023819058